These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 20700111
1. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice. Fakhfakh R, Michaud A, Tremblay JP. Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111 [Abstract] [Full Text] [Related]
2. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal. Benabdallah BF, Bouchentouf M, Tremblay JP. Transplantation; 2005 Jun 27; 79(12):1696-702. PubMed ID: 15973171 [Abstract] [Full Text] [Related]
3. Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice. Fakhfakh R, Lee SJ, Tremblay JP. Cell Transplant; 2012 Jun 27; 21(7):1419-30. PubMed ID: 22449443 [Abstract] [Full Text] [Related]
4. Losartan enhances the success of myoblast transplantation. Fakhfakh R, Lamarre Y, Skuk D, Tremblay JP. Cell Transplant; 2012 Jun 27; 21(1):139-52. PubMed ID: 21535912 [Abstract] [Full Text] [Related]
5. Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice. Benabdallah BF, Bouchentouf M, Rousseau J, Bigey P, Michaud A, Chapdelaine P, Scherman D, Tremblay JP. Cell Transplant; 2008 Jun 27; 17(3):337-50. PubMed ID: 18522236 [Abstract] [Full Text] [Related]
6. Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice. Benabdallah BF, Bouchentouf M, Rousseau J, Tremblay JP. Cell Transplant; 2009 Jun 27; 18(7):709-18. PubMed ID: 19520047 [Abstract] [Full Text] [Related]
7. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy. Kimura E, Han JJ, Li S, Fall B, Ra J, Haraguchi M, Tapscott SJ, Chamberlain JS. Hum Mol Genet; 2008 Aug 15; 17(16):2507-17. PubMed ID: 18511457 [Abstract] [Full Text] [Related]
12. Expression rate of myogenic regulatory factors and muscle growth factor after botulinum toxin A injection in the right masseter muscle of dystrophin deficient (mdx) mice. Botzenhart UU, Gerlach R, Gredes T, Rentzsch I, Gedrange T, Kunert-Keil C. Adv Clin Exp Med; 2019 Jan 15; 28(1):11-18. PubMed ID: 30085421 [Abstract] [Full Text] [Related]
13. Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy. Estrellas KM, Chung L, Cheu LA, Sadtler K, Majumdar S, Mula J, Wolf MT, Elisseeff JH, Wagner KR. J Biol Chem; 2018 Oct 05; 293(40):15594-15605. PubMed ID: 30139748 [Abstract] [Full Text] [Related]
19. Combined effect of AAV-U7-induced dystrophin exon skipping and soluble activin Type IIB receptor in mdx mice. Hoogaars WM, Mouisel E, Pasternack A, Hulmi JJ, Relizani K, Schuelke M, Schirwis E, Garcia L, Ritvos O, Ferry A, 't Hoen PA, Amthor H. Hum Gene Ther; 2012 Dec 05; 23(12):1269-79. PubMed ID: 22894762 [Abstract] [Full Text] [Related]
20. Exercise improves the success of myoblast transplantation in mdx mice. Bouchentouf M, Benabdallah BF, Mills P, Tremblay JP. Neuromuscul Disord; 2006 Aug 05; 16(8):518-29. PubMed ID: 16919954 [Abstract] [Full Text] [Related] Page: [Next] [New Search]